loadpatents
name:-0.015066146850586
name:-0.010445117950439
name:-0.00050902366638184
Lippa; Arnold S. Patent Filings

Lippa; Arnold S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lippa; Arnold S..The latest application filed is for "methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders".

Company Profile
0.7.12
  • Lippa; Arnold S. - Ridgewood NJ
  • Lippa; Arnold S. - New York NY
  • Lippa, Arnold S - Ridgewood NJ
  • Lippa; Arnold S. - Tucson AZ
  • Lippa; Arnold S. - Franklin Lakes NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods And Compositions Employing Bicifadine For Treating Disability Or Functional Impairment Associated With Acute Pain, Chronic Pain, Or Neuropathic Disorders
App 20170165228 - Lippa; Arnold S. ;   et al.
2017-06-15
Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders
Grant 9,393,204 - Lippa , et al. July 19, 2
2016-07-19
Methods And Compositions Employing Bicifadine For Treating Disability Or Functional Impairment Associated With Acute Pain, Chronic Pain, Or Neuropathic Disorders
App 20130345280 - Lippa; Arnold S. ;   et al.
2013-12-26
Methods And Compositions For Controlling Body Weight And Appetite
App 20080234354 - LIPPA; Arnold S. ;   et al.
2008-09-25
Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders
App 20080081834 - Lippa; Arnold S. ;   et al.
2008-04-03
Methods and compositions for the treatment of metabolic syndrome
App 20080081781 - Lippa; Arnold S. ;   et al.
2008-04-03
Salts And Co-Crystals of Pyrazolopyrimidine Compounds, Compositions Thereof And Methods For Their Production And Use
App 20080045547 - LIPPA; Arnold S. ;   et al.
2008-02-21
Methods and compositions employing bicifadine for the treatment of acute pain, chronic pain, and symptoms of neuropathic disorders
App 20080027119 - Lippa; Arnold S. ;   et al.
2008-01-31
Methods and compositions for controlling body weight and appetite
App 20070225351 - Lippa; Arnold S. ;   et al.
2007-09-27
Methods and compositions for the treatment of neuropathies and related disorders
App 20070082939 - Lippa; Arnold S. ;   et al.
2007-04-12
(+)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof
Grant 7,098,229 - Lippa , et al. August 29, 2
2006-08-29
(-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders
App 20060173064 - Lippa; Arnold S. ;   et al.
2006-08-03
(+)-1-(3,4-dichlorrophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof
App 20040132797 - Lippa, Arnold S ;   et al.
2004-07-08
Tinnitus masking using ultrasonic signals
Grant 6,377,693 - Lippa , et al. April 23, 2
2002-04-23
Frequency transpositional hearing aid with digital and single sideband modulation
Grant 6,173,062 - Dibachi , et al. January 9, 2
2001-01-09
Frequency transpositional hearing aid with single sideband modulation
Grant 6,169,813 - Richardson , et al. January 2, 2
2001-01-02
Virus inactivation
Grant 4,857,514 - Lippa , et al. August 15, 1
1989-08-15
Fluorescence immunoassay involving energy transfer between two fluorophores
Grant 4,777,128 - Lippa October 11, 1
1988-10-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed